Press Releases Year None202420232022202120202019201820172015 April 15, 2024 ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC April 8, 2024 ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual Meeting April 5, 2024 ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) April 4, 2024 ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences March 11, 2024 ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates March 6, 2024 ORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference March 5, 2024 ORIC Pharmaceuticals Announces Multiple Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting March 1, 2024 ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) February 14, 2024 ORIC Pharmaceuticals to Participate in the Citi 2024 Virtual Oncology Leadership Summit February 2, 2024 ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 14